336 related articles for article (PubMed ID: 32507576)
1. Multipotent mesenchymal stromal cells in kidney transplant recipients: The next big thing?
Sergeant E; Buysse M; Devos T; Sprangers B
Blood Rev; 2021 Jan; 45():100718. PubMed ID: 32507576
[TBL] [Abstract][Full Text] [Related]
2. Mesenchymal stromal cells in renal transplantation: opportunities and challenges.
Casiraghi F; Perico N; Cortinovis M; Remuzzi G
Nat Rev Nephrol; 2016 Apr; 12(4):241-53. PubMed ID: 26853275
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and Safety of Bone Marrow-Derived Mesenchymal Stem Cells for Chronic Antibody-Mediated Rejection After Kidney Transplantation- A Single-Arm, Two-Dosing-Regimen, Phase I/II Study.
Wei Y; Chen X; Zhang H; Su Q; Peng Y; Fu Q; Li J; Gao Y; Li X; Yang S; Ye Q; Huang H; Deng R; Li G; Xu B; Wu C; Wang J; Zhang X; Su X; Liu L; Xiang AP; Wang C
Front Immunol; 2021; 12():662441. PubMed ID: 34248942
[TBL] [Abstract][Full Text] [Related]
4. Adipose tissue-derived multipotent stromal cells have a higher immunomodulatory capacity than their bone marrow-derived counterparts.
Melief SM; Zwaginga JJ; Fibbe WE; Roelofs H
Stem Cells Transl Med; 2013 Jun; 2(6):455-63. PubMed ID: 23694810
[TBL] [Abstract][Full Text] [Related]
5. Autologous bone marrow derived mesenchymal stromal cell therapy in combination with everolimus to preserve renal structure and function in renal transplant recipients.
Reinders ME; Bank JR; Dreyer GJ; Roelofs H; Heidt S; Roelen DL; Al Huurman V; Lindeman J; van Kooten C; Claas FH; Fibbe WE; Rabelink TJ; de Fijter JW
J Transl Med; 2014 Dec; 12():331. PubMed ID: 25491391
[TBL] [Abstract][Full Text] [Related]
6. Bone Marrow Mesenchymal Stromal Cells Induce Proliferative, Cytokinic and Molecular Changes During the T Cell Response: The Importance of the IL-10/CD210 Axis.
Najar M; Raicevic G; Fayyad-Kazan H; De Bruyn C; Bron D; Toungouz M; Lagneaux L
Stem Cell Rev Rep; 2015 Jun; 11(3):442-52. PubMed ID: 25326368
[TBL] [Abstract][Full Text] [Related]
7. TGF-β1-Licensed Murine MSCs Show Superior Therapeutic Efficacy in Modulating Corneal Allograft Immune Rejection In Vivo.
Lynch K; Treacy O; Chen X; Murphy N; Lohan P; Islam MN; Donohoe E; Griffin MD; Watson L; McLoughlin S; O'Malley G; Ryan AE; Ritter T
Mol Ther; 2020 Sep; 28(9):2023-2043. PubMed ID: 32531237
[TBL] [Abstract][Full Text] [Related]
8. Mesenchymal Stem Cells Attenuate the Adverse Effects of Immunosuppressive Drugs on Distinct T Cell Subopulations.
Hajkova M; Hermankova B; Javorkova E; Bohacova P; Zajicova A; Holan V; Krulova M
Stem Cell Rev Rep; 2017 Feb; 13(1):104-115. PubMed ID: 27866327
[TBL] [Abstract][Full Text] [Related]
9. Human fetal liver MSCs are more effective than adult bone marrow MSCs for their immunosuppressive, immunomodulatory, and Foxp3
Yu Y; Valderrama AV; Han Z; Uzan G; Naserian S; Oberlin E
Stem Cell Res Ther; 2021 Feb; 12(1):138. PubMed ID: 33597011
[TBL] [Abstract][Full Text] [Related]
10. Impact of Mesenchymal Stromal Cells and Their Extracellular Vesicles in a Rat Model of Kidney Rejection.
Ramirez-Bajo MJ; Rovira J; Lazo-Rodriguez M; Banon-Maneus E; Tubita V; Moya-Rull D; Hierro-Garcia N; Ventura-Aguiar P; Oppenheimer F; Campistol JM; Diekmann F
Front Cell Dev Biol; 2020; 8():10. PubMed ID: 32064259
[TBL] [Abstract][Full Text] [Related]
11. Immunomodulatory effect of human bone marrow-derived mesenchymal stromal/stem cells on peripheral blood T cells from rheumatoid arthritis patients.
Pedrosa M; Gomes J; Laranjeira P; Duarte C; Pedreiro S; Antunes B; Ribeiro T; Santos F; Martinho A; Fardilha M; Domingues MR; Abecasis M; P da Silva JA; Paiva A
J Tissue Eng Regen Med; 2020 Jan; 14(1):16-28. PubMed ID: 31502378
[TBL] [Abstract][Full Text] [Related]
12. Rapamycin Augments Immunomodulatory Properties of Bone Marrow-Derived Mesenchymal Stem Cells in Experimental Autoimmune Encephalomyelitis.
Togha M; Jahanshahi M; Alizadeh L; Jahromi SR; Vakilzadeh G; Alipour B; Gorji A; Ghaemi A
Mol Neurobiol; 2017 May; 54(4):2445-2457. PubMed ID: 26971291
[TBL] [Abstract][Full Text] [Related]
13. Marrow Mesenchymal Stem Cells Effectively Reduce Histologic Changes in a Rat Model of Chronic Renal Allograft Rejection.
Yu P; Wang Z; Liu Y; Xiao Z; Guo Y; Li M; Zhao M
Transplant Proc; 2017 Nov; 49(9):2194-2203. PubMed ID: 29149982
[TBL] [Abstract][Full Text] [Related]
14. Prostaglandin E2 plays a key role in the immunosuppressive properties of adipose and bone marrow tissue-derived mesenchymal stromal cells.
Yañez R; Oviedo A; Aldea M; Bueren JA; Lamana ML
Exp Cell Res; 2010 Nov; 316(19):3109-23. PubMed ID: 20804749
[TBL] [Abstract][Full Text] [Related]
15. Autologous bone marrow-derived mesenchymal stromal cells for the treatment of allograft rejection after renal transplantation: results of a phase I study.
Reinders ME; de Fijter JW; Roelofs H; Bajema IM; de Vries DK; Schaapherder AF; Claas FH; van Miert PP; Roelen DL; van Kooten C; Fibbe WE; Rabelink TJ
Stem Cells Transl Med; 2013 Feb; 2(2):107-11. PubMed ID: 23349326
[TBL] [Abstract][Full Text] [Related]
16. Mesenchymal stem cell effects on T-cell effector pathways.
Duffy MM; Ritter T; Ceredig R; Griffin MD
Stem Cell Res Ther; 2011 Aug; 2(4):34. PubMed ID: 21861858
[TBL] [Abstract][Full Text] [Related]
17. Signature quality attributes of CD146
Bowles AC; Kouroupis D; Willman MA; Perucca Orfei C; Agarwal A; Correa D
Stem Cells; 2020 Aug; 38(8):1034-1049. PubMed ID: 32379908
[TBL] [Abstract][Full Text] [Related]
18. Resident vs nonresident multipotent mesenchymal stromal cell interactions with B lymphocytes result in disparate outcomes.
Lee W; Wang LT; Yen ML; Hsu PJ; Lee YW; Liu KJ; Lin KI; Su YW; Sytwu HK; Yen BL
Stem Cells Transl Med; 2021 May; 10(5):711-724. PubMed ID: 33506633
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Porcine Versus Human Mesenchymal Stromal Cells From Three Distinct Donor Locations for Cytotherapy.
Schweizer R; Waldner M; Oksuz S; Zhang W; Komatsu C; Plock JA; Gorantla VS; Solari MG; Kokai L; Marra KG; Rubin JP
Front Immunol; 2020; 11():826. PubMed ID: 32435248
[No Abstract] [Full Text] [Related]
20. Microenvironment in neuroblastoma: isolation and characterization of tumor-derived mesenchymal stromal cells.
Pelizzo G; Veschi V; Mantelli M; Croce S; Di Benedetto V; D'Angelo P; Maltese A; Catenacci L; Apuzzo T; Scavo E; Moretta A; Todaro M; Stassi G; Avanzini MA; Calcaterra V
BMC Cancer; 2018 Nov; 18(1):1176. PubMed ID: 30482160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
